• Info
  • Significant Ownership

Significant Ownership of Verve Capital Ltd

Location
Mid Levels
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Verve Capital Ltd.

Notify me when Verve Capital Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Verve Capital Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vor Biopharma Inc. Common Stock, $0.0001 par value per share 9.9% 761K Verve Capital Limited Sep 18, 2025

Schedules 13D/G Reported by Verve Capital Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.